NASDAQ:CRON Cronos Group (CRON) Stock Price, News & Analysis $3.22 +0.01 (+0.31%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$3.24 +0.02 (+0.59%) As of 10/2/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Cronos Group Stock (NASDAQ:CRON) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cronos Group alerts:Sign Up Key Stats Today's Range$3.19▼$3.2850-Day Range$2.72▼$3.5552-Week Range$2.28▼$3.61Volume1.24 million shsAverage Volume804,530 shsMarket Capitalization$1.19 billionP/E Ratio16.10Dividend YieldN/APrice Target$2.30Consensus RatingModerate Buy Company Overview Cronos Group Inc. is a Toronto-based cannabis company that develops, produces and distributes cannabis and cannabis-derived products. The company focuses on branded consumer products, including dried cannabis flower, pre-rolls, vaporizers, edibles and extracts. Cronos markets products under brands such as Spinach, PEACE NATURALS and Lord Jones. Brand availability varies by market and product category, with the company serving regulated cannabis markets in Canada and pursuing international opportunities where permitted by local laws. Founded in 2013, Cronos has expanded through brand development, acquisitions and strategic investments. The company is led by Mike Gorenstein, who serves as chairman and chief executive officer.AI Generated. May Contain Errors. Read More Cronos Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks27th Percentile Overall ScoreCRON MarketRank™: Cronos Group scored higher than 27% of companies evaluated by MarketBeat, and ranked 758th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.7 / 5Analyst RatingModerate Buy Consensus RatingCronos Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 3 buy ratings, 2 hold ratings, and no sell ratings.Downside RiskCronos Group has a consensus price target of $2.30, representing about 28.6% downside from its current price of $3.22.Amount of Analyst CoverageCronos Group has only been the subject of 2 research reports in the past 90 days.Read more about Cronos Group's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is 16.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.89.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is 16.10, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.77.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Cronos Group's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted0.96% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 4.11.Change versus previous monthShort interest in Cronos Group has recently increased by 0.26%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.86 News SentimentCronos Group has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cronos Group this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for CRON on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.MarketBeat Follows6 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by Insiders7.80% of the stock of Cronos Group is held by insiders.Percentage Held by Institutions8.71% of the stock of Cronos Group is held by institutions.Read more about Cronos Group's insider trading history. Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRON Stock News HeadlinesCritical Analysis: Theravance Biopharma (NASDAQ:TBPH) & Cronos Group (NASDAQ:CRON)September 30 at 4:45 AM | americanbankingnews.comCanadian Penny Stocks To Watch In September 2026September 27, 2026 | finance.yahoo.com$1,523 in morning income without touching a chart after 10 AMBetween 9:30 and 9:50 AM Eastern, Wall Street desks push nearly 25% of a stock's entire daily volume through the market in one chaotic 20-minute burst. Once the dust settles around 9:50 AM, that flow often reveals where a single ticker is likely headed for the rest of the morning. A recent closed-door briefing breaks down the exact data behind this pattern and how traders are watching it unfold.October 3 at 1:00 AM | ProsperityPub (Ad)Cronos Group Inc. (CRON:CA) Analyst/Investor Day - SlideshowSeptember 24, 2026 | seekingalpha.comCronos Hosts 2026 Investor DaySeptember 24, 2026 | finance.yahoo.comCronos Hosts 2026 Investor DaySeptember 24, 2026 | globenewswire.comLabaton Keller Sucharow LLP Announces a Proposed Settlement in the Cronos U.S. Securities SettlementSeptember 23, 2026 | finance.yahoo.com2 Cannabis Stocks That Are Quietly Trouncing the Market in 2026September 22, 2026 | fool.comSee More Headlines CRON Stock Analysis - Frequently Asked Questions How have CRON shares performed this year? Cronos Group's stock was trading at $2.63 at the start of the year. Since then, CRON shares have increased by 22.4% and is now trading at $3.22. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) issued its quarterly earnings data on Thursday, August, 6th. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.01 by $0.08. The business had revenue of $53.01 million for the quarter, compared to the consensus estimate of $44.20 million. Cronos Group had a net margin of 39.08% and a trailing twelve-month return on equity of 4.85%. Read the conference call transcript. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings8/06/2026Today10/03/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 CRON's financial health is in the Green zone, according to TradeSmith. CRON has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:CRON CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees610Year Founded2013Price Target and Rating Average Price Target for Cronos Group$2.30 High Price Target$2.30 Low Price Target$2.30 Potential Upside/Downside-28.6%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$0.20 Trailing P/E Ratio16.10 Forward P/E Ratio29.27 P/E GrowthN/ANet Income-$9.45 million Net Margins39.08% Pretax Margin38.23% Return on Equity4.85% Return on Assets4.62% Debt Debt-to-Equity RatioN/A Current Ratio16.18 Quick Ratio15.25 Sales & Book Value Annual Sales$179.09 million Price / Sales6.63 Cash Flow$0.01 per share Price / Cash Flow256.04 Book Value$3.00 per share Price / Book1.07Miscellaneous Outstanding Shares368,543,000Free Float339,797,000Market Cap$1.19 billion OptionableOptionable Beta0.90 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:CRON) was last updated on 10/3/2026 by MarketBeat.com Staff. From Our PartnersThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredEarth's biggest energy source: near Grand CanyonThe largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - an...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
